Drug & intervention
Ibrance
RxCUI 1601381
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
3 shownA Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world DatabaseNCT06962969 · 2025-06-30
COMPLETEDObservational Analysis of Palbociclib Treatment in Patients With First Line Therapy for Locally Advanced and/or Metastatic Breast CancerNCT04874025 · 2021-07-31
COMPLETEDA Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate CancerNCT02059213 · 2014-06-01
COMPLETEDConditions being studied
Research locations
Ann ArborMichigan, United States1BaltimoreMaryland, United States1BarcelonaCatalonia, Spain1ChicagoIllinois, United States1DuarteCalifornia, United States1MadridSpain1NashvilleTennessee, United States1New YorkNew York, United States1PhiladelphiaPennsylvania, United States1Salt Lake CityUtah, United States1St LouisMissouri, United States1ValenciaSpain1
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.